SR One News

BY CATEGORY: ALL / NOTABLE / CLINICAL IMPACT / NEW INVESTMENTS / FINANCING AND PARTNERSHIPS / PEOPLE

BY YEAR: 2023 / 2022 / 2021 / 2020

Frances Benson 2/16/22 Frances Benson 2/16/22

eFFECTOR Therapeutics appoints Kristen Harrington-Smith to Board of Directors

Read More

ARS Pharmaceuticals expands executive leadership team

Frances Benson 2/9/22 Frances Benson 2/9/22

ARS Pharmaceuticals expands executive leadership team

Read More

Design Therapeutics appoints Jae Kim as CMO

Frances Benson 2/1/22 Frances Benson 2/1/22

Design Therapeutics appoints Jae Kim as CMO

Read More

ADARx Pharmaceuticals expands leadership team

Frances Benson 1/25/22 Frances Benson 1/25/22

ADARx Pharmaceuticals expands leadership team

Read More

BioTheryX appoints Sahm Nasseri as CBO

Frances Benson 1/20/22 Frances Benson 1/20/22

BioTheryX appoints Sahm Nasseri as CBO

Read More

Second Genome appoints Joseph Dal Porto as CSO

Frances Benson 1/19/22 Frances Benson 1/19/22

Second Genome appoints Joseph Dal Porto as CSO

Read More

ADARx Pharmaceuticals appoints Dr. Hubert Chen as CMO

Frances Benson 1/5/22 Frances Benson 1/5/22

ADARx Pharmaceuticals appoints Dr. Hubert Chen as CMO

Read More

Palleon Pharmaceuticals appoints Denis Patrick to its Board of Directors

Frances Benson 12/16/21 Frances Benson 12/16/21

Palleon Pharmaceuticals appoints Denis Patrick to its Board of Directors

Read More

Palleon Pharmaceuticals appoints David Johnson to its Board of Directors

Frances Benson 11/2/21 Frances Benson 11/2/21

Palleon Pharmaceuticals appoints David Johnson to its Board of Directors

Read More

BioTheryX appoints Philippe Drouet as CEO

Frances Benson 10/28/21 Frances Benson 10/28/21

BioTheryX appoints Philippe Drouet as CEO

Read More

MiroBio appoints Dr. Carolin Barth as CEO

Frances Benson 9/21/21 Frances Benson 9/21/21

MiroBio appoints Dr. Carolin Barth as CEO

Read More

BioTheryX appoints three new members to its Board of Directors

Frances Benson 8/6/21 Frances Benson 8/6/21

BioTheryX appoints three new members to its Board of Directors

Read More

Bicycle Therapeutics enters exclusive license and collaboration agreement with Ionis

Frances Benson 7/13/21 Frances Benson 7/13/21

Bicycle Therapeutics enters exclusive license and collaboration agreement with Ionis

Read More

CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration

Frances Benson 6/15/21 Frances Benson 6/15/21

CRISPR Therapeutics and Capsida Biotherapeutics announce strategic collaboration

Read More

Tranquis Therapeutics appoints Frederic Godderis as COO and Jonas Hannestad as CMO

Frances Benson 5/26/21 Frances Benson 5/26/21

Tranquis Therapeutics appoints Frederic Godderis as COO and Jonas Hannestad as CMO

Read More

Turning Point Therapeutics appoints Mark Alles to chair its Board of Directors

Frances Benson 5/25/21 Frances Benson 5/25/21

Turning Point Therapeutics appoints Mark Alles to chair its Board of Directors

Read More

Fore Biotherapeutics strengthens leadership team

Frances Benson 5/19/21 Frances Benson 5/19/21

Fore Biotherapeutics strengthens leadership team

Read More

CRISPR Therapeutics and Nkarta announce global collaboration

Frances Benson 5/6/21 Frances Benson 5/6/21

CRISPR Therapeutics and Nkarta announce global collaboration

Read More

Frances Benson 5/4/21 Frances Benson 5/4/21

eFFECTOR Therapeutics and UCSF receive $5M from DARPA for Covid study

Read More

CRISPR Therapeutics amends partnership with Vertex Pharmaceuticals

Frances Benson 4/20/21 Frances Benson 4/20/21

CRISPR Therapeutics amends partnership with Vertex Pharmaceuticals

Read More